APA (7th ed.) Citation

Jonathan I. Silverberg, Andreas Wollenberg, Linda Stein Gold, James Del Rosso, Gil Yosipovitch, Peter Lio, . . . Sonja Ständer. (2024). Patients with Moderate-to-Severe Atopic Dermatitis Maintain Stable Response with No or Minimal Fluctuations with 1 Year of Lebrikizumab Treatment. Adis, Springer Healthcare.

Chicago Style (17th ed.) Citation

Jonathan I. Silverberg, et al. Patients with Moderate-to-Severe Atopic Dermatitis Maintain Stable Response with No or Minimal Fluctuations with 1 Year of Lebrikizumab Treatment. Adis, Springer Healthcare, 2024.

MLA (9th ed.) Citation

Jonathan I. Silverberg, et al. Patients with Moderate-to-Severe Atopic Dermatitis Maintain Stable Response with No or Minimal Fluctuations with 1 Year of Lebrikizumab Treatment. Adis, Springer Healthcare, 2024.